Final height of short normal children treated with growth hormone

Lancet

Volumn 348, Issue 9019, 1996, Pages 13-16

  Hindmarsh, Peter C ^a   Brook, Charles G D ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN GROWTH HORMONE;

ARTICLE; BLOOD PRESSURE; BODY FAT; BODY HEIGHT; BONE AGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLUCOSE METABOLISM; GROWTH DISORDER; GROWTH RATE; HUMAN; LONG TERM CARE; MALE; MATURATION; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; SEX DIFFERENCE; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030572464     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)01038-0     Document Type: Article

References (18)

1. Hindmarsh P, Smith PJ, Brook CGD, Matthews DR. The relationship between height velocity and GH secretion in short prepubertal children. Glin Endocrinol 1987; 27: 581-91.
2. Tanner JM, Whitehouse RH, Hughes PCR, Vince FP. Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children with growth hormone deficiency, low birth weight, inherited smallness, Turner's syndrome and other complaints. Arch Dis Child 1971; 46: 745-82.
3. Bercu BB, Shulman D, Root AW, Spilliotis BE. Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion. J Clin Endocrinol Metab 1986; 63: 709-16.
4. Hindmarsh PC, Brook CGD. Effect of growth hormone on short normal children. BMJ 1987; 295: 573-77.
5. Tanner JM, Whitehouse RH, Cameron N, et al. Assessment of skeletal maturity and prediction of adult height (TW2 method). London: Academic Press, 1983.
6. Marshall WA. Puberty. In: Falkner F, Tanner JM, eds. Human growth 2: postnatal growth. London: Baillière Tindall, 1978: 141-81.
7. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity: British children, 1965. Part II. Arch Dis Child 1966; 41: 613-35.
8. Report of the Second Task Force on blood pressure control in children - 1987. Pediatrics 1987; 79: 1-25.
9. Morgan CR, Lazarow A. Immunoassay of insulin: two antibody system. Diabetes 1963; 12: 115-26.
10. Loche S, Cambiaso P, Setzu Set al. Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature. J Pediatr. 125:1994;196-200.
11. Zadik Z, Mira U, Landau H. Final height after growth hormone therapy in peripubertal boys with a subnormal integrated concentration of growth hormone. Horm Res 1992; 37: 150-55.
12. Zadik A, Landau H, Limoni Y, Lieberman E Predictors of growth response to growth hormone in otherwise normal short children. J Pediatr. 121:1992;44-48.
13. Lesage C, Walker J, Landier F, Chatelain P, Chaussain JL, Bougnéres PF Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency. J Pediatr. 119:1991;29-34.
14. Bundak R, Hindmarsh PC, Smith PJ, Brook CGD. Long-term auxologic effects of human growth hormone. J Pediatr 1988; 112: 875-79.
15. Job J-C, Toublanc JE, Landier F. Growth of short normal children in puberty treated for 3 years with growth hormone alone or in association with gonadotropin-releasing hormone agonist. Horm Res 1994; 41: 177-84.
16. Bengtsson B-̊A, Eden S, Löhn L, et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993; 76: 309-17.
17. Skuse D, Gilmour J, Tian CS, Hindmarsh PC Psychosocial assessment of children with short stature: a preliminary report. Acta Paediatr Scand. 406(suppl):1994;11-16.
18. Voss LD, Mulligan J. The short normal child in school: self esteem, behaviour, and attainment before puberty (the Wessex Growth Study). In: Stabler B, Underwood LE, eds. Growth, stature and adaptation. Chapel Hill: University of North Carolina, 1994: 47-64.